Bio-Rad Laboratories, Inc. (BIO)

NYSE: BIO · Real-Time Price · USD

372.43

+2.48 (0.67%)

At close: Oct 26, 2026, 4:00 PM EDT

372.43

0.00 (0.00%)

After-hours: Oct 26, 2026, 7:30 PM EDT

Bio-Rad Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	9,958	8,212	9,182	9,399	12,460	22,439
Market Cap Growth	10.18%	-10.57%	-2.31%	-24.57%	-44.47%	29.37%
Enterprise Value	9,710	8,189	8,948	9,046	11,989	21,328
Last Close Price	372.43	302.99	328.51	322.89	420.49	755.57

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	45.11	10.81	-	-	-	5.28
Forward PE	40.71	28.94	28.85	26.51	28.66	59.87
PS Ratio	3.85	3.18	3.58	3.52	4.45	7.68
PB Ratio	1.39	1.10	1.40	1.08	1.30	1.64
P/TBV Ratio	1.55	1.23	1.57	1.17	1.40	1.72
P/FCF Ratio	28.20	21.92	31.71	43.08	152.70	41.88
P/OCF Ratio	20.22	15.43	20.17	25.07	64.10	33.52
PEG Ratio	-	2.29	2.40	6.63	2.71	4.28

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.75	3.17	3.49	3.39	4.28	7.30
EV/EBITDA Ratio	22.02	18.97	20.30	17.68	19.34	30.37
EV/EBIT Ratio	35.66	30.76	30.94	24.74	24.84	37.77
EV/FCF Ratio	27.50	21.86	30.90	41.46	146.93	39.81

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.19	0.19	0.21	0.16	0.14	0.02
Debt / EBITDA Ratio	2.69	2.78	2.69	2.44	2.05	0.30
Debt / FCF Ratio	3.88	3.70	4.75	6.44	17.01	0.42
Net Debt / Equity Ratio	-0.04	-0.02	-0.04	-0.02	-0.04	-0.05
Net Debt / EBITDA Ratio	-0.56	-0.36	-0.66	-0.39	-0.65	-0.92
Net Debt / FCF Ratio	-0.70	-0.42	-1.00	-0.92	-4.93	-1.21
Asset Turnover	0.25	0.26	0.24	0.21	0.18	0.19
Inventory Turnover	1.57	1.65	1.52	1.65	1.91	2.11
Quick Ratio	2.15	3.89	4.55	4.03	4.04	1.90
Current Ratio	3.14	5.62	6.48	5.83	5.55	2.92
Return on Equity (ROE)	3.11%	10.84%	-24.09%	-6.94%	-31.14%	36.11%
Return on Assets (ROA)	1.66%	1.67%	1.67%	1.77%	1.93%	2.29%
Return on Invested Capital (ROIC)	2.54%	2.99%	3.90%	4.12%	4.34%	3.98%
Return on Capital Employed (ROCE)	2.90%	2.60%	3.30%	3.10%	3.70%	3.30%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.22%	9.25%	-20.08%	-6.78%	-29.11%	18.96%
FCF Yield	3.55%	4.56%	3.15%	2.32%	0.66%	2.39%
Buyback Yield / Dilution	3.11%	3.31%	3.41%	1.93%	1.40%	-0.16%

SEC Filings: 10-K · 10-Q